AIOPTIMUS Trademark

Trademark Overview


On Friday, January 22, 2021, a trademark application was filed for AIOPTIMUS with the United States Patent and Trademark Office. The USPTO has given the AIOPTIMUS trademark a serial number of 90483207. The federal status of this trademark filing is REGISTERED as of Tuesday, May 31, 2022. This trademark is owned by AINovo Biotech Inc.. The AIOPTIMUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Development of computer programs for simulating laboratory experiments; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of online non-downloadable simulation software for modeling biophysical protein simulations for the purposes of developing bioactive molecules in the field of pharmaceuticals, biotechnology, and medicine; Software as a service (SAAS) services featuring software for developing bioactive molecules for therapeutic and diagnostic applications through the use of computational methods informed by reinforcement learning, computer vision, generative machine learning, supervised machine learning, unsupervised machine learning, and natural language processing algorithms for the purposes of optimizing pharmaceutical, biotechnological, and medical drugs
aioptimus

General Information


Serial Number90483207
Word MarkAIOPTIMUS
Filing DateFriday, January 22, 2021
Status700 - REGISTERED
Status DateTuesday, May 31, 2022
Registration Number6742515
Registration DateTuesday, May 31, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements


Pseudo MarkARTIFICIAL INTELLIGENCE OPTIMUS
Goods and ServicesPharmaceutical research and development; Development of computer programs for simulating laboratory experiments; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing temporary use of online non-downloadable simulation software for modeling biophysical protein simulations for the purposes of developing bioactive molecules in the field of pharmaceuticals, biotechnology, and medicine; Software as a service (SAAS) services featuring software for developing bioactive molecules for therapeutic and diagnostic applications through the use of computational methods informed by reinforcement learning, computer vision, generative machine learning, supervised machine learning, unsupervised machine learning, and natural language processing algorithms for the purposes of optimizing pharmaceutical, biotechnological, and medical drugs

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 23, 2021
Primary Code042
First Use Anywhere DateWednesday, January 20, 2021
First Use In Commerce DateWednesday, January 20, 2021

Trademark Owner History


Party NameAINovo Biotech Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGilbert, AZ 85233

Party NameAINovo Biotech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGilbert, AZ 85233

Party NameAINovo Biotech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGilbert, AZ 85233

Trademark Events


Event DateEvent Description
Tuesday, May 31, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 31, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 9, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 10, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 10, 2021NON-FINAL ACTION E-MAILED
Tuesday, August 10, 2021NON-FINAL ACTION WRITTEN
Tuesday, August 3, 2021ASSIGNED TO EXAMINER
Friday, April 23, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 26, 2021NEW APPLICATION ENTERED IN TRAM